Personalized Hemophilia Care Through Telemedicine and Adherence Monitoring

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The TEMPO project collects and analyzes big data from patients with hemophilia to improve adherence, monitoring, and early diagnosis of joint bleeds. It aims to tailor treatment regimens to each patient within a personalized medicine framework. The approach relies on telemedicine to support ongoing monitoring and timely management of hemarthrosis, potentially enabling earlier intervention. The study is interventional and runs at a single lead center, enrolling adults who own a smartphone. Exclusion criteria remove individuals with other inflammatory or degenerative arthritis conditions that could confound outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* informed consent
* age (minimum 18 years)
* hemophilia
* having a smartphone

Exclusion Criteria:

* autoimmune, inflammatory or degenerative diseases that cause arthritis

Where it's running

• Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
  Milan, Italy Recruiting

Study contacts

• Study coordinator: Roberta Gualtierotti, Professor
• Email: roberta.gualtierotti@unimi.it
• Phone: +39 0255034072

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Checks how well the Figure-of-Eight Walk and Weight-Bearing Lunge tests measure movement in adults with hemophilia

  This observational study tests two movement tests to see if they reliably reflect mobility in adults with hemophilia who have a history of joint bleeding.

  Recruiting Yuzuncu Yil University · Van · NCT07851922

• Multimodal Telerehabilitation vs Face-to-Face Care for Adults with Hemophilia and Chronic Pain

  This trial tests whether a 6-week telerehabilitation program combining pain education and therapeutic exercise works as well as in-person care for adults with hemophilia and chronic pain.

  Recruiting University of Chile · Santiago, Santiago Metropolitan · NCT07682519

• PCC treatment for hemophilia A patients with inhibitors

  This trial tests whether giving prothrombin complex concentrate (PCC) during bleeding episodes can stop bleeds in people aged 12–65 with hemophilia A who have inhibitors.

  Recruiting Phase 4 Institute of Hematology & Blood Diseases Hospital, China · Tianjin, Tianjin Municipality · NCT07406139

• Fitusiran prophylaxis for boys aged 1 to under 12 with severe hemophilia A or B

  This study tests whether fitusiran given as prophylaxis can reduce bleeding in boys aged 1 to under 12 with severe hemophilia A or B, with or without inhibitors.

  Recruiting at 37 sites Phase 3 Sanofi · Los Angeles, California and 36 other locations · NCT07285460

• High-altitude stem cell and bone marrow transplant registry on the Qinghai-Tibet Plateau

  This project will collect clinical data and blood/bone marrow samples from people having hematopoietic stem cell transplants on the Qinghai‑Tibet Plateau to see how high altitude affects transplant outcomes and recovery.

  Recruiting Affiliated Hospital of Qinghai University · Xining, Qinghai · NCT07205523

• Monitoring anti‑TFPI antibodies in adult men with severe hemophilia

  This project tests blood-based lab methods to monitor anti-TFPI antibodies in adult men with severe hemophilia who are on prophylaxis.

  Recruiting Hospices Civils de Lyon · Bron and 1 other locations · NCT07101926

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.